Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced and Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07156253
What this trial is testing

Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorOvarian CancerBreast Cancer+2 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd 110
Early research (Phase 1)Ended earlyNCT03295942
What this trial is testing

OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMetastatic Cancer
OncoMed Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT04495296
What this trial is testing

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Cancer
Transcenta Therapeutics (Hangzhou) Co., Ltd. 320
Early research (Phase 1)Study completedNCT02049593
What this trial is testing

PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor
Jonsson Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT03744468
What this trial is testing

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-inHNSCC for Phase 2 Dose ExpansionNSCLC for Phase 2 Dose Expansion
BeiGene 147
Early research (Phase 1)Study completedNCT03736850
What this trial is testing

Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
CStone Pharmaceuticals 17
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Early research (Phase 1)Study completedNCT00504296
What this trial is testing

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 39
Testing effectiveness (Phase 2)Ended earlyNCT00959946
What this trial is testing

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more
Pfizer 32
Early research (Phase 1)Looking for participantsNCT07613723
What this trial is testing

Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies

Who this might be right for
Ovarian CancerSquamous Non-Small Cell Lung Cancer (NSCLC)Synovial Sarcomas+1 more
Zelluna Immunotherapy AS 9
Early research (Phase 1)Study completedNCT04200963
What this trial is testing

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderBladder Cancer+18 more
Ikena Oncology 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134
What this trial is testing

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
CancerTumor, SolidAdvanced Solid Tumor+19 more
Salubris Biotherapeutics Inc 263
Early research (Phase 1)Looking for participantsNCT07230977
What this trial is testing

GenSci139 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd. 280
Early research (Phase 1)Looking for participantsNCT06752681
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Day One Biopharmaceuticals, Inc. 300
Early research (Phase 1)Study completedNCT00005791
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Early research (Phase 1)Study completedNCT01924689
What this trial is testing

Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 24
Early research (Phase 1)Study completedNCT02174172
What this trial is testing

Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Cancers
Hoffmann-La Roche 158
Early research (Phase 1)Not Yet RecruitingNCT07763639
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid Tumors

Who this might be right for
Head and Neck TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT05512377
What this trial is testing

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Who this might be right for
Pancreatic NeoplasmsSolid TumorsBiliary Tract Cancer+2 more
Boehringer Ingelheim 99
Next Page